provider: cyberian
model: deep-research
cached: false
start_time: '2026-01-22T18:09:05.099188'
end_time: '2026-01-22T18:26:39.816339'
duration_seconds: 1054.72
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: ICA1
gene_symbol: ICA1
uniprot_accession: Q05084
protein_description: 'RecName: Full=Islet cell autoantigen 1; AltName: Full=69 kDa
islet cell autoantigen; Short=ICA69; AltName: Full=Islet cell autoantigen p69;
Short=ICAp69; Short=p69;'
gene_info: Name=ICA1;
organism_full: Homo sapiens (Human).
protein_family: Not specified in UniProt
protein_domains: AH/BAR_dom_sf. (IPR027267); AH_dom. (IPR010504); Islet_autoAg_Ica1/Ica1-like.
(IPR024114); Islet_autoAg_Ica1_C. (IPR006723); Arfaptin (PF06456)
provider_config:
timeout: 1800
max_retries: 3
parameters:
allowed_domains: []
agent_type: claude
port: 3284
skip_permissions: true
citation_count: 15

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

• UniProt Accession: Q05084
• Protein Description: RecName: Full=Islet cell autoantigen 1; AltName: Full=69 kDa islet cell autoantigen; Short=ICA69; AltName: Full=Islet cell autoantigen p69; Short=ICAp69; Short=p69;
• Gene Information: Name=ICA1;
• Organism (full): Homo sapiens (Human).
• Protein Family: Not specified in UniProt
• Key Domains: AH/BAR_dom_sf. (IPR027267); AH_dom. (IPR010504); Islet_autoAg_Ica1/Ica1-like. (IPR024114); Islet_autoAg_Ica1_C. (IPR006723); Arfaptin (PF06456)

MANDATORY VERIFICATION STEPS:

1. Check if the gene symbol "ICA1" matches the protein description above
2. Verify the organism is correct: Homo sapiens (Human).
3. Check if protein family/domains align with what you find in literature
4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'ICA1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene ICA1 (gene ID: ICA1, UniProt: Q05084) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

ICA1 (Islet Cell Autoantigen 1): A Comprehensive Review

Introduction and Summary

Islet cell autoantigen 1 (ICA1), also known as ICA69 or ICAp69, is a 483-amino acid protein originally identified as an autoantigen in type 1 diabetes mellitus [pietropaolo-1993-ica69-discovery-abstract]. Encoded by the ICA1 gene on chromosome 7p21.3, this protein has emerged as a multifunctional regulator with critical roles in dense-core vesicle biogenesis, neuroendocrine secretion, and membrane trafficking at the trans-Golgi network (TGN). ICA69 contains an N-terminal BAR (Bin/Amphiphysin/Rvs) domain that enables it to sense membrane curvature and facilitate vesicle budding, functions that are conserved from nematodes to humans [bhimsen-2000-ric19-abstract]. The protein is predominantly expressed in tissues with high secretory activity, including the brain, pancreas, and stomach mucosa, where it localizes to the Golgi complex and immature secretory granules [spitzenberger-2003-golgi-abstract].

ICA69 functions primarily through heterodimerization with PICK1 (protein interacting with C kinase 1), another BAR domain protein [cao-2013-pick1-ica69-trafficking-abstract]. These heteromeric complexes play essential roles in insulin granule formation and maturation in pancreatic beta cells. Knockout studies in mice have demonstrated that loss of either ICA69 or PICK1 leads to glucose intolerance, reduced insulin secretion, and accumulation of proinsulin, establishing these proteins as key regulators of metabolic homeostasis [cao-2013-pick1-ica69-trafficking-abstract]. Beyond its role in glucose metabolism, ICA69 has been implicated in neurotransmitter release, synaptic plasticity, and has been identified as a shared autoantigen in type 1 diabetes, Sjögren's syndrome, and potentially other autoimmune conditions [winer-2002-sjogren-abstract][fan-2014-multiorgan-autoimmunity-abstract]. Recent genetic studies have also linked ICA1 variants to autism spectrum disorder and schizophrenia [kushima-2018-cnv-asd-scz-abstract].

Gene and Protein Structure

The human ICA1 gene spans approximately 296 kilobases on chromosome 7p21.3 and contains 21 exons that can produce multiple transcript variants through alternative splicing. The canonical protein product consists of 483 amino acids with a predicted molecular weight of approximately 69 kDa, hence the alternative designation ICA69 [pietropaolo-1993-ica69-discovery-abstract]. When the protein was first cloned in 1993, it showed no significant homology to any known sequences in GenBank, except for two short regions of limited similarity with bovine serum albumin [pietropaolo-1993-ica69-discovery-abstract].

Subsequent structural analyses revealed that ICA69 contains an N-terminal arfaptin homology/BAR domain superfamily region (approximately residues 1-250) that shares similarity with the ARF1-binding region of arfaptin proteins [spitzenberger-2003-golgi-abstract]. This domain adopts a banana-shaped, anti-parallel coiled-coil structure characteristic of BAR domain proteins, enabling it to sense and induce membrane curvature [cao-2013-pick1-ica69-trafficking-abstract]. Although no crystal structure of ICA69 itself has been published, its BAR domain structure has been inferred from homologous proteins; the crystal structure of Drosophila Amphiphysin BAR domain shows striking similarity to the GTPase-binding domain of Arfaptin 2, despite weak sequence conservation, suggesting a conserved structural fold across the BAR domain superfamily.

The C-terminal region of ICA69, designated ICAC (ICA69 C-terminal domain), is unique to the ICA69 protein family and contributes to protein-protein interactions and subcellular targeting [wang-2013-ica69-pkca-trafficking-abstract]. Importantly, the ICAC domain represents a functionally distinct module from the N-terminal BAR domain, with different binding properties. Studies have demonstrated that ICAC directly associates with PICK1 and plays a critical role in regulating the trafficking of the PICK1-PKCα (protein kinase C alpha) complex to the plasma membrane [wang-2013-ica69-pkca-trafficking-abstract]. Overexpression of ICAC specifically interferes with PKCα-mediated PICK1 translocation, whereas the BAR domain-containing region does not. This dual-domain architecture allows ICA69 to participate in both membrane curvature sensing (via the BAR domain) and signaling pathway regulation (via ICAC).

A paralogue of ICA1, designated ICA1L (ICA1-like), exists in vertebrates and shows similar domain architecture [he-2015-ica1l-pick1-acrosome-abstract]. While ICA69 is the predominant PICK1 binding partner in brain and pancreas, ICA1L serves this role in the testes, where it is essential for acrosome formation during spermiogenesis [he-2015-ica1l-pick1-acrosome-abstract]. The evolutionary conservation of the ICA69 family is remarkable, with the Caenorhabditis elegans homologue RIC-19 (resistance to inhibitors of cholinesterase-19) sharing 33% identity with human ICA69 across the conserved domains, including a 58% conserved stretch that likely represents critical functional motifs [bhimsen-2000-ric19-abstract].

Subcellular Localization

ICA69 exhibits a complex subcellular distribution pattern that reflects its dynamic role in vesicular trafficking. The majority of the cellular ICA69 pool exists as a soluble cytosolic protein; however, a significant subpopulation associates with membranes, particularly those of the Golgi complex and immature secretory granules [spitzenberger-2003-golgi-abstract][bhimsen-2000-ric19-abstract]. Immunofluorescence microscopy in insulinoma INS-1 cells revealed that ICA69 is enriched in the perinuclear region, colocalizing with markers of the Golgi apparatus and, to a lesser extent, with immature insulin-containing secretory granules [spitzenberger-2003-golgi-abstract].

Immunoelectron microscopy studies confirmed this localization and provided a critical insight into the dynamics of ICA69 association with secretory granules: virtually no ICA69 immunogold labeling was observed on mature secretory granules near the plasma membrane [spitzenberger-2003-golgi-abstract]. This observation was subsequently explained by studies showing that ICA69 is present on immature granules near the TGN as part of PICK1-ICA69 heteromeric complexes, but dissociates from granules during maturation, leaving only PICK1 on mature granules [cao-2013-pick1-ica69-trafficking-abstract].

In neuronal tissue, subcellular fractionation of mouse brain demonstrated that while most ICA69 is cytosolic, a subpopulation is membrane-bound and coenriched with synaptic vesicles [bhimsen-2000-ric19-abstract]. In pancreatic beta cells, ICA69 displayed punctate distribution that was distinct from insulin-containing dense-core granules, suggesting association with synaptic-like microvesicles or immature granule compartments rather than mature secretory granules [bhimsen-2000-ric19-abstract]. The tissue distribution of ICA69 correlates with secretory activity, with the highest expression levels found in brain, pancreas, and stomach mucosa, moderate levels in heart and thyroid, and low or absent expression in skeletal muscle, placenta, spleen, and ovary [pietropaolo-1993-ica69-discovery-abstract].

Molecular Function: Role in Dense-Core Vesicle Biogenesis

The primary molecular function of ICA69 is to regulate the biogenesis and maturation of dense-core vesicles (DCVs), also known as large dense-core vesicles (LDCVs), in neuroendocrine cells. This function is mediated through its BAR domain, which can sense and induce membrane curvature, and through its obligate partnership with PICK1 [cao-2013-pick1-ica69-trafficking-abstract]. The current model of ICA69 function, derived primarily from studies in pancreatic beta cells and C. elegans neurons, positions it as a key player in the early stages of DCV formation at the TGN.

PICK1 and ICA69 form tight heteromeric complexes in pancreatic beta cells and mutually depend on each other for normal expression and stability [cao-2013-pick1-ica69-trafficking-abstract]. PICK1 deficiency in mice causes complete loss of ICA69 protein, despite normal ICA69 mRNA levels, indicating that the proteins stabilize each other through heterodimerization [cao-2013-pick1-ica69-trafficking-abstract]. The PICK1-ICA69 heterodimer directly assists in the process of budding from the TGN and regulates maturation of insulin granules [pihlstrøm-2022-pick1-variants-diabetes-abstract]. During this process, the BAR domains of both proteins work in concert to generate the membrane curvature necessary for vesicle budding, while PICK1's PDZ domain couples cargo proteins to the nascent vesicle.

A key feature of ICA69 function is its transient association with secretory granules. The protein is present on immature secretory granules near the TGN but dissociates as granules mature [cao-2013-pick1-ica69-trafficking-abstract][spitzenberger-2003-golgi-abstract]. This dynamic behavior suggests that ICA69 functions specifically in the early stages of granule biogenesis—potentially in membrane budding, cargo sorting, or the initial stages of granule maturation—but is not required for the later steps of granule trafficking or exocytosis. Recent work using advanced microscopy techniques demonstrated that PICK1 transiently associates with immature secretory granules before departing via vesicular budding, and ICA69 likely follows a similar pattern as part of the heteromeric complex [pihlstrøm-2022-pick1-variants-diabetes-abstract].

Lipid Binding and Membrane Interactions

The membrane-associated functions of ICA69 depend on its ability to bind phospholipids and sense membrane curvature through its BAR domain. Like other BAR domain proteins, ICA69 contains an amphipathic helix N-terminal to the BAR domain proper that contributes to phospholipid binding and membrane curvature sensing [pihlstrøm-2022-pick1-variants-diabetes-abstract]. The BAR domain adopts a crescent-shaped, positively charged concave surface that interacts with negatively charged lipid membranes, allowing it to both sense existing membrane curvature and actively induce curvature through electrostatic interactions.

Biochemical studies have demonstrated that the N-BAR domain of ICA69 (amino acids 1-234) can deform liposomes and induce tubular membrane structures in vitro. Within 10 minutes of incubation with liposomes, ICA69 induces tubular membrane structures; by 30 minutes, membrane vesicles become the predominant species, indicating that ICA69 can drive the complete membrane fission process [mallik-2017-drosophila-nmj-abstract]. This membrane-deforming activity is essential for its role in vesicle budding at the TGN.

The lipid binding properties of PICK1, and by extension the PICK1-ICA69 heterodimer, have been more extensively characterized. PICK1 directly binds to lipids, mainly phosphoinositides, via its BAR domain. Lipid binding of the PICK1 BAR domain is positively regulated by its PDZ domain and negatively regulated by its C-terminal acidic domain. In contrast to covalent lipid modifications like palmitoylation, the interaction of the PICK1-ICA69 complex with lipids is based on noncovalent electrostatic interactions, making the association with membranes highly dynamic. This allows the complex to be recruited to specific membrane regions when negatively charged lipids are enriched and to dissociate when the membrane becomes less charged—a property that likely underlies the transient association of ICA69 with maturing secretory granules.

Studies of PICK1 variants identified in diabetic patients have provided additional mechanistic insights. Four coding variants affecting positively charged arginine residues in the PICK1 BAR domain (R158Q, R185Q, R197Q, R247H) compromised membrane binding capacity [pihlstrøm-2022-pick1-variants-diabetes-abstract]. Paradoxically, these variants showed increased capacity to cause membrane fission, suggesting that the balance between membrane binding affinity and fission activity is critical for proper insulin granule biogenesis. Since PICK1-ICA69 heterodimers share similar lipid-binding properties, these findings have implications for understanding how the complex regulates membrane dynamics during DCV formation.

Role in ER-Golgi Trafficking and Rab2 Interaction

Beyond its role in DCV biogenesis at the TGN, ICA69 also functions earlier in the secretory pathway as an effector of the small GTPase Rab2, which regulates COPI vesicle transport between the endoplasmic reticulum (ER) and the Golgi complex [buffa-2008-rab2-effector-abstract]. In insulinoma INS-1 cells, ICA69 binds to Rab2 in a GTP-dependent manner, and Rab2 recruits ICA69 to membranes. This interaction places ICA69 at a critical juncture in the secretory pathway, where cargo proteins destined for secretory granules transit from the ER to the Golgi.

Functional studies revealed that overexpression of either Rab2 or ICA69 in insulinoma cells impaired the anterograde transport of secretory granule protein precursors, including pro-ICA512 (a transmembrane protein of insulin granules) and chromogranin A (a major lumenal cargo of DCVs) [buffa-2008-rab2-effector-abstract]. This overexpression also reduced stimulated insulin secretion. These findings suggest that ICA69, in partnership with Rab2, regulates the flow of cargo through the early secretory pathway and that the stoichiometry of these interactions is important for proper secretory function.

The involvement of ICA69 in Rab2-mediated ER-Golgi trafficking connects it to the broader machinery of DCV maturation. In C. elegans, the ICA69 homologue RIC-19 was identified as a RAB-2 effector in genetic screens for genes involved in DCV cargo retention during maturation [bhimsen-2000-ric19-abstract]. Eight genes have been identified as essential for immature DCV remodeling and cargo maintenance: UNC-108/RAB-2, RIC-19/ICA69, VPS-50, VPS-51, VPS-52, VPS-53, RUND-1, and HID-1. This places ICA69/RIC-19 within a conserved molecular network controlling DCV biogenesis from nematodes to mammals.

Role in Neuroendocrine Secretion and Synaptic Function

The demonstration that the C. elegans ICA69 homologue RIC-19 is required for normal neurotransmitter secretion provided the first functional evidence for ICA69's role in the regulated secretory pathway [bhimsen-2000-ric19-abstract]. The ric-19 deletion mutant exhibited striking resistance to aldicarb, an inhibitor of acetylcholinesterase. Since aldicarb resistance typically indicates reduced acetylcholine release, this phenotype demonstrated that RIC-19 is necessary for efficient neurotransmitter secretion. Importantly, the phenotype was rescued by transgenic expression of RIC-19, confirming the specificity of this function.

Studies in Drosophila melanogaster have extended these findings and revealed additional functions at the neuromuscular junction (NMJ). An RNAi screen targeting BAR-domain proteins identified ICA69 as one of the key regulators of morphological differentiation at the larval NMJ [mallik-2017-drosophila-nmj-abstract]. In Drosophila, ICA69 colocalizes with α-Spectrin at the NMJ and regulates the synaptic localization of ionotropic glutamate receptors (iGluRs). Full-length ICA69 induces filopodia formation in cultured cells, consistent with its membrane-deforming activity. Importantly, Rab2 functions genetically upstream of ICA69 in this context, regulating NMJ organization and iGluR targeting/retention by controlling ICA69 protein levels [mallik-2017-drosophila-nmj-abstract]. ICA69 mutants display reduced α-Spectrin immunoreactivity at the larval NMJ, indicating impaired cytoskeletal organization. These findings demonstrate that the Rab2-ICA69 pathway is evolutionarily conserved and plays a crucial role in synaptic organization across species.

In mammals, ICA69's role in neuronal function has been established through studies of ICA69 knockout mice. Recent work demonstrated that ICA69 is essential for activity-dependent synaptic strengthening, specifically long-term potentiation (LTP), a cellular mechanism underlying learning and memory [yang-2023-synaptic-plasticity-abstract]. ICA69 knockout mice showed selective deficits in LTP following theta-burst stimulation, with field excitatory postsynaptic potential amplitudes substantially reduced compared to wild-type mice for at least 90 minutes post-stimulation.

Remarkably, ICA69 knockout mice exhibited normal basal synaptic transmission. Postsynaptic AMPA receptor (AMPAR) levels remained normal, and miniature excitatory postsynaptic currents showed no differences between knockout and wild-type mice [yang-2023-synaptic-plasticity-abstract]. This indicates that ICA69 is specifically required for activity-dependent processes rather than constitutive synaptic function. The authors proposed that ICA69 facilitates forward trafficking of AMPAR-containing vesicles during LTP induction, drawing parallels to its established function in promoting insulin and growth hormone secretion in endocrine tissues.

The molecular mechanism underlying ICA69's role in synaptic plasticity involves regulation of PICK1 and protein kinase C alpha (PKCα) trafficking. Studies have shown that the C-terminal domain of ICA69 (ICAC) interacts with PICK1 and regulates the trafficking of the PICK1-PKCα complex to the plasma membrane [wang-2013-ica69-pkca-trafficking-abstract]. PKCα is a key kinase involved in the phosphorylation and internalization of AMPARs during long-term depression (LTD). MBP-ICAC fusion proteins significantly inhibited LTD at cerebellar Purkinje cell synapses, demonstrating that ICA69's regulation of PICK1-PKCα trafficking is functionally important for synaptic plasticity [wang-2013-ica69-pkca-trafficking-abstract]. Thus, ICA69 appears to serve as a bidirectional regulator of synaptic plasticity, affecting both LTP (through AMPAR insertion) and LTD (through PKCα-mediated AMPAR internalization), depending on the neuronal context and signaling state.

The behavioral consequences of ICA69 loss are significant. ICA69 knockout mice showed substantial learning and memory deficits in multiple cognitive tasks. In spatial memory tasks using the Y-maze, knockout mice showed discrimination indices near chance level (0.56 versus 0.70 for controls). Associative learning measured by inhibitory avoidance tasks was similarly impaired, with knockout animals showing no increased latency to enter the shock chamber 24 hours after training [yang-2023-synaptic-plasticity-abstract]. These findings establish ICA69 as an important regulator of cognitive function.

Connection to Type 1 Diabetes and Autoimmunity

ICA69 was originally identified through its recognition by autoantibodies in sera from relatives of patients with insulin-dependent diabetes mellitus (IDDM, now called type 1 diabetes, T1D) who subsequently progressed to overt disease [pietropaolo-1993-ica69-discovery-abstract]. The researchers screened a human islet cDNA expression library with cytoplasmic islet cell antibody-positive sera and identified ICA69 as a novel autoantigen. Subsequently, it was shown that sera from T1D patient relatives specifically react with recombinant ICA69 protein.

While ICA69 is recognized as a T1D autoantigen, it is not among the four major autoantibody markers currently used for clinical prediction of T1D progression (insulin autoantibodies, GAD65 autoantibodies, IA-2 autoantibodies, and ZnT8 autoantibodies). Nevertheless, ICA69 autoimmunity contributes to the broader autoimmune response targeting pancreatic islets. The localization of ICA69 to the insulin secretory granule membrane and its role in insulin granule biogenesis explain why it becomes a target of the autoimmune response—it is a component of the very organelles that define beta cell identity and function.

Studies in NOD (non-obese diabetic) mice, a model of spontaneous autoimmune diabetes, have provided mechanistic insights into ICA69 autoimmunity [fan-2014-multiorgan-autoimmunity-abstract]. NOD mice immunized with ICA69 polypeptides exhibited exacerbated inflammation not only in the pancreatic islets but also in the salivary glands. This multi-organ autoimmunity reflects the expression pattern of ICA69 in multiple secretory tissues. Genetically modified mice with suboptimal thymic ICA69 expression (ICA69del/wt and Aire-ΔICA69 mice) showed inadequate central tolerance to ICA69, resulting in the escape of ICA69-reactive T cells to the periphery [fan-2014-multiorgan-autoimmunity-abstract]. These mice spontaneously developed coincident autoimmune responses affecting the pancreas, salivary glands, thyroid, and stomach.

The connection between ICA69 autoimmunity and Sjögren's syndrome, a chronic autoimmune disease characterized by lymphocytic infiltration and destruction of salivary and lacrimal glands, has been particularly well-characterized [winer-2002-sjogren-abstract]. Disruption of the ICA69 locus in NOD mice prevented lacrimal gland disease and greatly reduced salivary gland disease. T-cell and B-cell autoreactivity against ICA69 was found in patients with primary Sjögren's syndrome, and autoantibodies to ICA69 were detected in Western blots of patient sera. Importantly, treatment with an ICA69-targeted peptide vaccine successfully reduced established disease in mice, suggesting therapeutic potential [winer-2002-sjogren-abstract].

Connection to Neurodevelopmental Disorders

Emerging genetic evidence has linked ICA1 to neurodevelopmental disorders, including autism spectrum disorder (ASD) and schizophrenia. The SFARI (Simons Foundation Autism Research Initiative) Gene database classifies ICA1 as a "strong candidate" autism gene with a score of 2 [sfari-2019-ica1-summary]. Multiple lines of evidence support this association:

First, rare inherited duplications of the 7p21 chromosomal locus that includes ICA1 have been identified in ASD probands across multiple independent studies [sfari-2019-ica1-summary]. Second, a rare de novo missense variant in ICA1 was identified in an ASD proband from the Simons Simplex Collection. Third, and most significantly, a CNV analysis of 1,108 ASD cases, 2,458 schizophrenia cases, and 2,095 controls from a Japanese population demonstrated significant enrichment of exonic CNVs affecting ICA1 in the combined neurodevelopmental disease cohort [kushima-2018-cnv-asd-scz-abstract]. Specifically, 6 CNVs were found in ASD/schizophrenia cases versus 0 in controls (odds ratio 9.19, P = 1.0×10⁻⁵).

The neurobiological basis for ICA1's involvement in neurodevelopmental disorders likely relates to its role in synaptic plasticity and learning [yang-2023-synaptic-plasticity-abstract]. The finding that ICA69 knockout mice have selective deficits in LTP and impaired learning and memory provides a plausible mechanism by which ICA1 dysfunction could contribute to cognitive symptoms in ASD and schizophrenia. Additionally, ICA69's role in DCV biogenesis could affect the release of neuromodulators and neuropeptides from dense-core vesicles, which are important for proper brain development and function.

Emerging Roles in Cardiovascular Disease

Recent research has revealed unexpected functions for ICA69 beyond its established roles in vesicle biogenesis and neuroendocrine secretion. A 2022 study identified ICA69 as a regulator of ferroptosis in sepsis-induced cardiac dysfunction [kong-2022-ferroptosis-cardiac-abstract]. In lipopolysaccharide (LPS)-stimulated models, ICA69 expression increases significantly, and ICA69 deficiency in LPS-induced mice markedly improved survival and cardiac function while reducing inflammatory cytokines and ferroptotic markers.

Mechanistically, elevated ICA69 promotes STING (stimulator of interferon genes) trafficking, leading to increased lipid peroxidation and ferroptosis-mediated cardiac injury [kong-2022-ferroptosis-cardiac-abstract]. ICA69 knockdown reversed ferroptotic markers including prostaglandin endoperoxide synthase 2 (PTGS2), malondialdehyde (MDA), 4-hydroxynonenal (4HNE), glutathione peroxidase 4 (GPX4), and superoxide dismutase (SOD) levels. Clinically, higher ICA69 levels were found in peripheral blood mononuclear cells from septic patients, and ICA69 expression correlated positively with sepsis severity as measured by APACHE II scores.

This novel function of ICA69 in regulating STING trafficking and ferroptosis extends its known role as a trafficking regulator to a new cellular context. The mechanism may relate to ICA69's established function in membrane trafficking, with STING being another cargo whose trafficking is influenced by ICA69. These findings suggest that ICA69 could be a potential therapeutic target for sepsis-induced cardiomyopathy, though the precise relationship between this inflammatory role and its canonical function in DCV biogenesis requires further investigation.

Open Questions

Several important questions about ICA69 function remain unanswered and warrant further investigation:

1. Mechanism of granule dissociation: What molecular signals trigger the dissociation of ICA69 from maturing secretory granules while PICK1 remains associated? Is this related to changes in membrane lipid composition, pH, or the acquisition of specific cargo proteins during maturation?

2. Tissue-specific functions: While ICA69 and PICK1 form heterodimers in brain and pancreas, and ICA1L-PICK1 heterodimers predominate in testis, what determines this tissue specificity? Are there additional ICA69 binding partners that confer tissue-specific functions?

3. Therapeutic potential: Given that ICA69-targeted peptide vaccination reduced Sjögren's syndrome in mice, could similar approaches be developed for T1D prevention in at-risk individuals? What are the risks of manipulating immunity to a widely expressed protein?

4. Neurodevelopmental mechanisms: How do ICA1 mutations contribute to ASD and schizophrenia at the cellular and circuit levels? Which neuronal subtypes are most affected by ICA69 dysfunction?

5. Structural basis of PICK1-ICA69 interaction: What is the precise structural arrangement of the PICK1-ICA69 BAR domain heterodimer? How does this differ from PICK1 homodimers, and how does this difference affect membrane binding and vesicle biogenesis?

6. Additional GTPase interactions: While ICA69 binds Rab2, does it also interact with other small GTPases such as ARF1, given its arfaptin homology? What is the full repertoire of ICA69 protein interactions?

7. Role in growth hormone secretion: Some evidence suggests ICA69 is involved in growth hormone secretion from pituitary somatotrophs. What is the specific mechanism, and does ICA69 dysfunction contribute to growth abnormalities?

References

1. [pietropaolo-1993-ica69-discovery-abstract] Pietropaolo M, Castaño L, Babu S, Buelow R, Kuo YL, Martin S, Martin A, Powers AC, Prochazka M, Naggert J, et al. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest. 1993 Jul;92(1):359-71. PMID: 8326004. DOI: 10.1172/JCI116574

2. [spitzenberger-2003-golgi-abstract] Spitzenberger F, Pietropaolo S, Verkade P, Habermann B, Lacas-Gervais S, Mziaut H, Pietropaolo M, Solimena M. Islet cell autoantigen of 69 kDa is an arfaptin-related protein associated with the Golgi complex of insulinoma INS-1 cells. J Biol Chem. 2003 Jul 11;278(28):26166-73. PMID: 12682071. DOI: 10.1074/jbc.M213222200

3. [buffa-2008-rab2-effector-abstract] Buffa L, Fuchs E, Pietropaolo M, Barr F, Solimena M. ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells. Eur J Cell Biol. 2008 Apr;87(4):197-209. PMID: 18187231. DOI: 10.1016/j.ejcb.2007.11.003

4. [cao-2013-pick1-ica69-trafficking-abstract] Cao M, Mao Z, Kam C, Xiao N, Cao X, Shen C, Cheng KKY, Xu A, Lee KM, Jiang L, Xia J. PICK1 and ICA69 control insulin granule trafficking and their deficiencies lead to impaired glucose tolerance. PLoS Biol. 2013 Apr 23;11(4):e1001541. PMID: 23630453. PMCID: PMC3635858. DOI: 10.1371/journal.pbio.1001541

5. [he-2015-ica1l-pick1-acrosome-abstract] He J, Xia M, Tsang WH, Chow KL, Xia J. ICA1L forms BAR-domain complexes with PICK1 and is crucial for acrosome formation in spermiogenesis. J Cell Sci. 2015 Oct 15;128(20):3822-36. PMID: 26306493. DOI: 10.1242/jcs.173534

6. [pihlstrøm-2022-pick1-variants-diabetes-abstract] Pihlstrøm HK, Bhuin R, Hansen SH, Bhowmik D, et al. Coding variants identified in patients with diabetes alter PICK1 BAR domain function in insulin granule biogenesis. J Clin Invest. 2022 Feb 15;132(4):e144904. PMID: 35077398. PMCID: PMC8884907. DOI: 10.1172/JCI144904

7. [bhimsen-2000-ric19-abstract] The Diabetes Autoantigen ICA69 and Its Caenorhabditis elegans Homologue, ric-19, Are Conserved Regulators of Neuroendocrine Secretion. Mol Biol Cell. 2000 Oct;11(10):3277-90. PMCID: PMC14991. DOI: 10.1091/mbc.11.10.3277

8. [winer-2002-sjogren-abstract] Winer S, Astsaturov I, Cheung R, Tsui H, Song A, Gaedigk R, Winer D, Sampson A, McKerlie C, Bookman A, Dosch HM. Primary Sjögren's syndrome and deficiency of ICA69. Lancet. 2002 Oct 5;360(9340):1063-9. PMID: 12383988. DOI: 10.1016/S0140-6736(02)11144-5

9. [fan-2014-multiorgan-autoimmunity-abstract] Fan Y, et al. Compromised central tolerance of ICA69 induces multiple organ autoimmunity. J Autoimmun. 2014 Sep;53:10-25. PMID: 25088457. DOI: 10.1016/j.jaut.2014.07.001

10. [yang-2023-synaptic-plasticity-abstract] Yang C, Bhinge A, et al. ICA69 regulates activity-dependent synaptic strengthening and learning and memory. Front Mol Neurosci. 2023;16:1171432. DOI: 10.3389/fnmol.2023.1171432

11. [kushima-2018-cnv-asd-scz-abstract] Kushima I, et al. Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights. Cell Rep. 2018;24(11):2838-2856.

12. [sfari-2019-ica1-summary] SFARI Gene Database - ICA1 Entry. https://gene.sfari.org/database/human-gene/ICA1. Score 2 (Strong Candidate). Last updated October 1, 2019.

13. [mallik-2017-drosophila-nmj-abstract] Mallik B, Dwivedi MK, Mushtaq Z, Kumari M, Verma PK, Kumar V. Regulation of neuromuscular junction organization by Rab2 and its effector ICA69 in Drosophila. Development. 2017 Jun 1;144(11):2032-2044. PMID: 28455372. DOI: 10.1242/dev.145920

14. [wang-2013-ica69-pkca-trafficking-abstract] Wang Z, Wang YN, Sun CL, Yang D, Su LD, Xie YJ, Zhou L, Wang Y, Shen Y. C-terminal domain of ICA69 interacts with PICK1 and acts on trafficking of PICK1-PKCα complex and cerebellar plasticity. PLoS One. 2013 Dec 16;8(12):e83862. PMID: 24358315. DOI: 10.1371/journal.pone.0083862

15. [kong-2022-ferroptosis-cardiac-abstract] Kong C, Ni X, Wang Y, Zhang A, Zhang Y, Lin F, Li S, Lv Y, Zhu J, Yao X, Dai Q, Mo Y, Wang J. ICA69 aggravates ferroptosis causing septic cardiac dysfunction via STING trafficking. Cell Death Discov. 2022 Apr 9;8(1):187. PMID: 35397620. DOI: 10.1038/s41420-022-00957-y

Citations

1. bhimsen-2000-ric19-abstract.md
2. buffa-2008-rab2-effector-abstract.md
3. cao-2013-pick1-ica69-trafficking-abstract.md
4. fan-2014-multiorgan-autoimmunity-abstract.md
5. he-2015-ica1l-pick1-acrosome-abstract.md
6. kong-2022-ferroptosis-cardiac-abstract.md
7. kushima-2018-cnv-asd-scz-abstract.md
8. mallik-2017-drosophila-nmj-abstract.md
9. pietropaolo-1993-ica69-discovery-abstract.md
10. pihlstrøm-2022-pick1-variants-diabetes-abstract.md
11. sfari-2019-ica1-summary.md
12. spitzenberger-2003-golgi-abstract.md
13. wang-2013-ica69-pkca-trafficking-abstract.md
14. winer-2002-sjogren-abstract.md
15. yang-2023-synaptic-plasticity-abstract.md

provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-14T17:16:00.295548'
end_time: '2025-12-14T17:25:41.523393'
duration_seconds: 581.23
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: ICA1
gene_symbol: ICA1
uniprot_accession: Q05084
protein_description: 'RecName: Full=Islet cell autoantigen 1; AltName: Full=69 kDa
islet cell autoantigen; Short=ICA69; AltName: Full=Islet cell autoantigen p69;
Short=ICAp69; Short=p69;'
gene_info: Name=ICA1;
organism_full: Homo sapiens (Human).
protein_family: Not specified in UniProt
protein_domains: AH/BAR_dom_sf. (IPR027267); AH_dom. (IPR010504); Islet_autoAg_Ica1/Ica1-like.
(IPR024114); Islet_autoAg_Ica1_C. (IPR006723); Arfaptin (PF06456)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 10

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

• UniProt Accession: Q05084
• Protein Description: RecName: Full=Islet cell autoantigen 1; AltName: Full=69 kDa islet cell autoantigen; Short=ICA69; AltName: Full=Islet cell autoantigen p69; Short=ICAp69; Short=p69;
• Gene Information: Name=ICA1;
• Organism (full): Homo sapiens (Human).
• Protein Family: Not specified in UniProt
• Key Domains: AH/BAR_dom_sf. (IPR027267); AH_dom. (IPR010504); Islet_autoAg_Ica1/Ica1-like. (IPR024114); Islet_autoAg_Ica1_C. (IPR006723); Arfaptin (PF06456)

MANDATORY VERIFICATION STEPS:

1. Check if the gene symbol "ICA1" matches the protein description above
2. Verify the organism is correct: Homo sapiens (Human).
3. Check if protein family/domains align with what you find in literature
4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'ICA1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene ICA1 (gene ID: ICA1, UniProt: Q05084) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

• UniProt Accession: Q05084
• Protein Description: RecName: Full=Islet cell autoantigen 1; AltName: Full=69 kDa islet cell autoantigen; Short=ICA69; AltName: Full=Islet cell autoantigen p69; Short=ICAp69; Short=p69;
• Gene Information: Name=ICA1;
• Organism (full): Homo sapiens (Human).
• Protein Family: Not specified in UniProt
• Key Domains: AH/BAR_dom_sf. (IPR027267); AH_dom. (IPR010504); Islet_autoAg_Ica1/Ica1-like. (IPR024114); Islet_autoAg_Ica1_C. (IPR006723); Arfaptin (PF06456)

MANDATORY VERIFICATION STEPS:

1. Check if the gene symbol "ICA1" matches the protein description above
2. Verify the organism is correct: Homo sapiens (Human).
3. Check if protein family/domains align with what you find in literature
4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'ICA1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene ICA1 (gene ID: ICA1, UniProt: Q05084) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research report: Human ICA1 (ICA69; UniProt Q05084)

Identity verification and overview
ICA1 encodes islet cell autoantigen 69 kDa (ICA69), a BAR-domain protein with an N‑terminal amphipathic helix that oligomerizes (preferentially with PICK1) and functions in membrane remodeling and secretory trafficking. It was originally identified as an islet cell autoantigen in type 1 diabetes. In neurons, ICA69 participates in the AMPAR complex through PICK1 and contributes to activity-dependent synaptic strengthening. In endocrine cells, it regulates insulin secretory granule biogenesis and trafficking, functioning as a Rab2 effector. These conclusions are supported by recent primary studies and mechanistic syntheses (https://doi.org/10.3389/fnmol.2023.1171432; https://doi.org/10.1091/mbc.e24-05-0201; https://doi.org/10.1038/s41420-022-00957-y) (chiu2023ica69regulatesactivitydependent pages 1-2, chiu2023ica69regulatesactivitydependent pages 2-3, chiu2023ica69regulatesactivitydependent pages 14-15, lai2024sodiumarseniteinduces pages 11-11, kong2022ica69aggravatesferroptosis pages 3-5).

1) Key concepts and definitions with current understanding
- Protein family/domains: ICA69 is a BAR-domain protein with an N-terminal amphipathic helix; together these motifs confer phospholipid binding, membrane curvature sensing, and remodeling. ICA69 forms heteromeric BAR-domain complexes with PICK1 and can self‑oligomerize. Its C‑terminal region mediates PICK1 interaction and trafficking effects (https://doi.org/10.3389/fnmol.2023.1171432) (chiu2023ica69regulatesactivitydependent pages 2-3, chiu2023ica69regulatesactivitydependent pages 14-15).
- Cellular localization: ICA69 localizes to ER–Golgi and Golgi-derived secretory vesicles in endocrine cells and neurons. In dendrites, ICA69‑associated Golgi-derived pools likely supply AMPARs during NMDAR-dependent LTP; a distinct PICK1 pool resides near synapses (https://doi.org/10.3389/fnmol.2023.1171432) (chiu2023ica69regulatesactivitydependent pages 12-13).
- Molecular functions: ICA69 acts as a Rab2 effector in ER→Golgi trafficking and promotes budding and post-Golgi trafficking of insulin/growth hormone secretory vesicles. In neurons, ICA69 regulates AMPAR trafficking by retaining PICK1/AMPAR complexes in Golgi-derived pools and releasing them upon LTP to permit synaptic insertion (https://doi.org/10.3389/fnmol.2023.1171432) (chiu2023ica69regulatesactivitydependent pages 2-3, chiu2023ica69regulatesactivitydependent pages 12-13, chiu2023ica69regulatesactivitydependent pages 13-14).
- Role as autoantigen: ICA69 was cloned as a 69 kDa islet cell autoantigen associated with T1D. It remains referenced among islet autoantigens in reviews of diabetes autoimmunity (JCI and related sources) (chiu2023ica69regulatesactivitydependent pages 1-2, chiu2023ica69regulatesactivitydependent pages 14-15).

2) Recent developments and latest research (2023–2024 priority)
- Synaptic plasticity and cognition (2023): Ica1 knockout mice exhibit selective deficits in NMDAR-dependent LTP at Schaffer collateral→CA1 synapses, with normal LTD and basal transmission, linking ICA69 to activity-dependent AMPAR delivery and learning/memory behavior. Mechanistically, ICA69 stabilizes PICK1 and helps mobilize a Golgi-derived AMPAR pool during LTP (Frontiers in Molecular Neuroscience, May 2023; https://doi.org/10.3389/fnmol.2023.1171432) (chiu2023ica69regulatesactivitydependent pages 1-2, chiu2023ica69regulatesactivitydependent pages 8-10, chiu2023ica69regulatesactivitydependent pages 12-13).
- Stress-induced reconfiguration of PICK1–ICA69 interactions (2024): Sodium arsenite rapidly (>90% of cells within 1 h) induces perinuclear aggresomes and shifts PICK1 toward homodimerization at the expense of PICK1–ICA69 heteromers, consistent with stress-triggered proteostasis changes that could transiently disengage ICA69 from PICK1-dependent trafficking (Molecular Biology of the Cell, Oct 2024; https://doi.org/10.1091/mbc.e24-05-0201) (lai2024sodiumarseniteinduces pages 8-10).
- Inflammation/ferroptosis in sepsis (anchor 2022): ICA69 expression rises with LPS; ICA69 binds and modulates STING protein levels/activation, promoting ferroptosis and septic cardiac dysfunction. ICA69 deficiency improves survival, heart function, and reduces ROS/lipid peroxidation and restores GPX4 in mice; elevated ICA69 is observed in PBMCs of septic patients (Cell Death Discovery, Apr 2022; https://doi.org/10.1038/s41420-022-00957-y) (kong2022ica69aggravatesferroptosis pages 3-5).

3) Current applications and real-world implementations
- Autoantibody biomarker context: ICA69 is part of the historical islet autoantigen repertoire in T1D research, though routine clinical staging relies more on IAA, GADA, IA-2A, and ZnT8A. Nonetheless, ICA69 remains relevant in mechanistic autoimmunity discussions and epitope discovery pipelines (chiu2023ica69regulatesactivitydependent pages 1-2, chiu2023ica69regulatesactivitydependent pages 14-15).
- Neuroscience research models: Ica1 knockout mice are used to probe LTP mechanisms and cognition; ICA69/PICK1 manipulations in neurons are employed to dissect Golgi-derived AMPAR supply and secretory pathway contributions to synaptic plasticity (https://doi.org/10.3389/fnmol.2023.1171432) (chiu2023ica69regulatesactivitydependent pages 8-10, chiu2023ica69regulatesactivitydependent pages 12-13).
- Critical care/cardiology experimental context: Targeting ICA69–STING trafficking has been proposed as a strategy to mitigate sepsis-induced cardiomyopathy by limiting ferroptosis; supportive animal and ex vivo human PBMC data exist (https://doi.org/10.1038/s41420-022-00957-y) (kong2022ica69aggravatesferroptosis pages 3-5).
- Cell stress/proteostasis studies: Arsenite-driven aggresome assays now consider PICK1–ICA69 stoichiometry as a variable influencing aggregate handling and stress granule/aggresome interplay (https://doi.org/10.1091/mbc.e24-05-0201) (lai2024sodiumarseniteinduces pages 8-10).

4) Expert opinions and analysis from authoritative sources
- Mechanistic integration across systems: BAR-domain proteins commonly sculpt membranes and organize trafficking hubs. ICA69’s BAR/AH architecture, preferential heteromerization with PICK1, and Rab2 effector function unify endocrine and neuronal roles: vesicle budding at Golgi membranes and regulated cargo delivery (AMPARs in neurons; insulin/granule cargo in endocrine cells). Stress conditions that favor PICK1 homodimers may transiently decouple this machinery, with potential impacts on secretion and synaptic plasticity (chiu2023ica69regulatesactivitydependent pages 2-3, chiu2023ica69regulatesactivitydependent pages 4-5, lai2024sodiumarseniteinduces pages 8-10).
- Disease relevance synthesis: ICA69’s classical identity as a T1D autoantigen is consistent with its abundant expression in secretory β-cells and involvement in insulin granule biology. Its interaction with innate-immune adaptor STING in sepsis suggests a broader immunometabolic role where secretory-pathway scaffolds control inflammatory signaling and cell-death programs such as ferroptosis (kong2022ica69aggravatesferroptosis pages 3-5, chiu2023ica69regulatesactivitydependent pages 1-2, chiu2023ica69regulatesactivitydependent pages 14-15).

5) Relevant statistics and data from recent studies
- ICA69–PICK1 interaction bias: In heterologous cells, GFP‑ICA69 binds myc‑PICK1 ~35× more than myc‑ICA69; GFP‑PICK1 binds myc‑ICA69 ~19× more than myc‑PICK1. Co‑expression with PICK1 increases ICA69 expression ~90×, indicating mutual stabilization (https://doi.org/10.3389/fnmol.2023.1171432) (chiu2023ica69regulatesactivitydependent pages 4-5).
- Synaptic phenotypes (Ica1 KO): ICA69 in KO hippocampus drops to ~2% of WT; PICK1 to ~33% of WT. TBS‑induced LTP is reduced: WT 184.9 ± 9.8% vs KO 158.6 ± 6.2% at 55–60 min (p = 0.028); WT 170.9 ± 8.7% vs KO 142.1 ± 6.0% at 85–90 min (p = 0.001). Basal mEPSCs unchanged (https://doi.org/10.3389/fnmol.2023.1171432) (chiu2023ica69regulatesactivitydependent pages 8-10).
- Stress-induced aggresomes (2024): Sodium arsenite induces aggresomes in >90% of cells within 1 h and shifts PICK1 toward homodimers over PICK1–ICA69 heteromers by +59.8 ± 3.31% (P = 0.003) (https://doi.org/10.1091/mbc.e24-05-0201) (lai2024sodiumarseniteinduces pages 8-10).
- Sepsis/ferroptosis metrics (2022): In the LPS (10 mg/kg) mouse model, ICA69 deficiency improved survival (n = 10/group), decreased MDA/4HNE/lipid ROS, and restored GPX4; ICA69 levels were higher in PBMCs from septic patients (n = 52) (https://doi.org/10.1038/s41420-022-00957-y) (kong2022ica69aggravatesferroptosis pages 3-5).

Limitations and open questions
- Direct ARF-family binding: While ICA69 is frequently labeled a Rab2 effector, the precise set of small GTPases (Rab vs ARF) and binding interfaces in human cells require further biochemical dissection in 2023–2024 primary literature; most contemporary mechanistic insights remain from earlier foundational studies and are summarized in 2023 work (chiu2023ica69regulatesactivitydependent pages 2-3, chiu2023ica69regulatesactivitydependent pages 12-13).
- Autoantibody clinical utility: Contemporary clinical screening panels emphasize GADA, IAA, IA-2A, ZnT8A; recent 2023–2024 population studies prioritizing ICA69 antibody assays are limited in the present corpus (chiu2023ica69regulatesactivitydependent pages 1-2, chiu2023ica69regulatesactivitydependent pages 14-15).

Direct links and citations
- Chiu SL, Chen CM, Huganir RL. ICA69 regulates activity-dependent synaptic strengthening and learning and memory. Frontiers in Molecular Neuroscience. May 2023. https://doi.org/10.3389/fnmol.2023.1171432 (chiu2023ica69regulatesactivitydependent pages 1-2, chiu2023ica69regulatesactivitydependent pages 8-10, chiu2023ica69regulatesactivitydependent pages 12-13, chiu2023ica69regulatesactivitydependent pages 4-5).
- Lai JHC, Tsogka M, Xia J. Sodium arsenite induces aggresome formation by promoting PICK1 BAR domain homodimer formation. Molecular Biology of the Cell. Oct 2024. https://doi.org/10.1091/mbc.e24-05-0201 (lai2024sodiumarseniteinduces pages 8-10, lai2024sodiumarseniteinduces pages 11-11).
- Kong C et al. ICA69 aggravates ferroptosis causing septic cardiac dysfunction via STING trafficking. Cell Death Discovery. Apr 2022. https://doi.org/10.1038/s41420-022-00957-y (kong2022ica69aggravatesferroptosis pages 3-5).

Embedded artifact of recent key studies

Table: Concise summary table of primary 2022–2024 studies on human ICA1/ICA69 showing system context, main findings, key quantitative results, and DOI links; includes neuronal LTP/AMPAR trafficking (Chiu 2023), arsenite-induced PICK1 aggresomes (Lai 2024), and STING/ferroptosis in sepsis (Kong 2022).

References

1. (chiu2023ica69regulatesactivitydependent pages 1-2): Shu-Ling Chiu, Chih-Ming Chen, and Richard L. Huganir. Ica69 regulates activity-dependent synaptic strengthening and learning and memory. Frontiers in Molecular Neuroscience, May 2023. URL: https://doi.org/10.3389/fnmol.2023.1171432, doi:10.3389/fnmol.2023.1171432. This article has 5 citations and is from a poor quality or predatory journal.

2. (chiu2023ica69regulatesactivitydependent pages 2-3): Shu-Ling Chiu, Chih-Ming Chen, and Richard L. Huganir. Ica69 regulates activity-dependent synaptic strengthening and learning and memory. Frontiers in Molecular Neuroscience, May 2023. URL: https://doi.org/10.3389/fnmol.2023.1171432, doi:10.3389/fnmol.2023.1171432. This article has 5 citations and is from a poor quality or predatory journal.

3. (chiu2023ica69regulatesactivitydependent pages 14-15): Shu-Ling Chiu, Chih-Ming Chen, and Richard L. Huganir. Ica69 regulates activity-dependent synaptic strengthening and learning and memory. Frontiers in Molecular Neuroscience, May 2023. URL: https://doi.org/10.3389/fnmol.2023.1171432, doi:10.3389/fnmol.2023.1171432. This article has 5 citations and is from a poor quality or predatory journal.

4. (lai2024sodiumarseniteinduces pages 11-11): John Ho Chun Lai, Marianthi Tsogka, and Jun Xia. Sodium arsenite induces aggresome formation by promoting pick1 bar domain homodimer formation. Molecular Biology of the Cell, Oct 2024. URL: https://doi.org/10.1091/mbc.e24-05-0201, doi:10.1091/mbc.e24-05-0201. This article has 0 citations and is from a domain leading peer-reviewed journal.

5. (kong2022ica69aggravatesferroptosis pages 3-5): Chang Kong, Xuqing Ni, Yixiu Wang, Anqi Zhang, Yingying Zhang, Feihong Lin, Shan Li, Ya Lv, Jingwen Zhu, Xinyu Yao, Qinxue Dai, Yunchang Mo, and Junlu Wang. Ica69 aggravates ferroptosis causing septic cardiac dysfunction via sting trafficking. Cell Death Discovery, Apr 2022. URL: https://doi.org/10.1038/s41420-022-00957-y, doi:10.1038/s41420-022-00957-y. This article has 59 citations and is from a peer-reviewed journal.

6. (chiu2023ica69regulatesactivitydependent pages 12-13): Shu-Ling Chiu, Chih-Ming Chen, and Richard L. Huganir. Ica69 regulates activity-dependent synaptic strengthening and learning and memory. Frontiers in Molecular Neuroscience, May 2023. URL: https://doi.org/10.3389/fnmol.2023.1171432, doi:10.3389/fnmol.2023.1171432. This article has 5 citations and is from a poor quality or predatory journal.

7. (chiu2023ica69regulatesactivitydependent pages 13-14): Shu-Ling Chiu, Chih-Ming Chen, and Richard L. Huganir. Ica69 regulates activity-dependent synaptic strengthening and learning and memory. Frontiers in Molecular Neuroscience, May 2023. URL: https://doi.org/10.3389/fnmol.2023.1171432, doi:10.3389/fnmol.2023.1171432. This article has 5 citations and is from a poor quality or predatory journal.

8. (chiu2023ica69regulatesactivitydependent pages 8-10): Shu-Ling Chiu, Chih-Ming Chen, and Richard L. Huganir. Ica69 regulates activity-dependent synaptic strengthening and learning and memory. Frontiers in Molecular Neuroscience, May 2023. URL: https://doi.org/10.3389/fnmol.2023.1171432, doi:10.3389/fnmol.2023.1171432. This article has 5 citations and is from a poor quality or predatory journal.

9. (lai2024sodiumarseniteinduces pages 8-10): John Ho Chun Lai, Marianthi Tsogka, and Jun Xia. Sodium arsenite induces aggresome formation by promoting pick1 bar domain homodimer formation. Molecular Biology of the Cell, Oct 2024. URL: https://doi.org/10.1091/mbc.e24-05-0201, doi:10.1091/mbc.e24-05-0201. This article has 0 citations and is from a domain leading peer-reviewed journal.

10. (chiu2023ica69regulatesactivitydependent pages 4-5): Shu-Ling Chiu, Chih-Ming Chen, and Richard L. Huganir. Ica69 regulates activity-dependent synaptic strengthening and learning and memory. Frontiers in Molecular Neuroscience, May 2023. URL: https://doi.org/10.3389/fnmol.2023.1171432, doi:10.3389/fnmol.2023.1171432. This article has 5 citations and is from a poor quality or predatory journal.

Citations

1. lai2024sodiumarseniteinduces pages 8-10
2. lai2024sodiumarseniteinduces pages 11-11
3. https://doi.org/10.3389/fnmol.2023.1171432;
4. https://doi.org/10.1091/mbc.e24-05-0201;
5. https://doi.org/10.1038/s41420-022-00957-y
6. https://doi.org/10.3389/fnmol.2023.1171432
7. https://doi.org/10.1091/mbc.e24-05-0201
8. https://doi.org/10.3389/fnmol.2023.1171432,
9. https://doi.org/10.1091/mbc.e24-05-0201,
10. https://doi.org/10.1038/s41420-022-00957-y,

provider: openai
model: o3-deep-research-2025-06-26
cached: true
start_time: '2025-11-03T23:06:26.382527'
end_time: '2025-11-03T23:06:26.384012'
duration_seconds: 0.0
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: Q05084
gene_symbol: ICA1
provider_config:
timeout: 600
max_retries: 3
parameters:
temperature: 0.1
top_p: 1.0
citation_count: 92

Question

Gene Research for Functional Annotation

Please provide a comprehensive research report on the gene ICA1 (Q05084) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Introduction

ICA1 (Islet Cell Autoantigen 1), also known as ICA69, is a human gene encoding a protein of approximately 483 amino acids that was first identified as an autoantigen in type 1 diabetes (pmc.ncbi.nlm.nih.gov). The ICA1 protein contains an arfaptin homology domain, indicating structural similarity to arfaptin proteins (pmc.ncbi.nlm.nih.gov). This domain is a type of BAR (Bin/Amphiphysin/Rvs) domain known for binding lipid membranes and sensing or inducing membrane curvature (www.bioch.ox.ac.uk). ICA1 is predominantly a cytosolic protein that can associate peripherally with intracellular membranes, especially the Golgi complex and immature secretory granules (www.wikidoc.org). It is broadly expressed in pancreatic islet β-cells and other neuroendocrine tissues (pmc.ncbi.nlm.nih.gov), consistent with its initial discovery as a target of autoimmune responses in endocrine disorders. While ICA1’s name and historical interest stem from autoimmunity, modern research has illuminated its fundamental role in vesicle formation and intracellular trafficking processes, rather than any enzymatic or transport activity. Below, we detail ICA1’s molecular function, the biological pathways it participates in, its subcellular localization, and the evidence linking ICA1 to specific cellular roles and diseases, with an emphasis on recent findings (2023–2024) from the scientific literature.

Structural Features and Localization

The ICA1 gene product is a BAR domain-containing protein approximately 69 kDa in size (483 amino acids) (pmc.ncbi.nlm.nih.gov). BAR domains are crescent-shaped dimerization modules that bind to curved membranes; accordingly, ICA1 often functions as a dimer or heterodimer that can “bend the lipid membrane” to shape vesicular structures (journals.plos.org). Notably, ICA1’s BAR domain is in its N-terminal half and is highly similar to that of arfaptins (pmc.ncbi.nlm.nih.gov), a family of proteins known to interact with Arf GTPases and membrane surfaces. This domain architecture enables ICA1 to exist in both soluble and membrane-bound states. Indeed, ICA1 is found diffusely in the cytosol as well as attached to membranes of the Golgi apparatus and secretory vesicles (www.wikidoc.org). Early cell biology studies localized ICA1 to the Golgi complex in insulin-secreting cells (pmc.ncbi.nlm.nih.gov), and it is particularly enriched on the trans-Golgi network (TGN) and on immature secretory granule membranes in pancreatic β-cells (journals.plos.org) (pmc.ncbi.nlm.nih.gov). These observations suggest that ICA1 dynamically shuttles between the cytosol and membranes during vesicle biogenesis. ICA1 lacks any known enzymatic active site or transmembrane region; instead, its primary structure is adapted for protein–protein and protein–lipid interactions that facilitate vesicle formation. The protein can form complexes with itself or other BAR domain proteins, and it has an affinity for curved phospholipid membranes (www.bioch.ox.ac.uk). This structural context underlies ICA1’s role as a scaffolding or adaptor protein in membrane trafficking rather than as a catalyst.

In terms of cellular distribution, ICA1 is predominantly expressed in secretory and neuroendocrine cells. For example, in humans and rodents it is highly expressed in pancreatic islets (insulin-producing β-cells) and in brain regions with dense synaptic activity (pmc.ncbi.nlm.nih.gov). Its conservation across species highlights its fundamental role: the Caenorhabditis elegans homolog of ICA1 (RIC-19) is required for neurotransmitter secretion in worms (pmc.ncbi.nlm.nih.gov). This evolutionary conservation – from worm neurons to human β-cells – underscores ICA1’s core function in vesicle dynamics across the neuroendocrine system. At the subcellular level, ICA1 has been observed at sites of vesicle budding and maturation. Specifically, immunolocalization experiments in pancreatic cells showed ICA1 on the cytosolic face of immature insulin granules budding from the TGN (journals.plos.org). Treatment of cells with brefeldin A (which blocks ER-to-Golgi and TGN export) causes ICA1 to accumulate at the TGN (journals.plos.org), consistent with ICA1 cycling on/off membranes during vesicle biogenesis. In summary, ICA1 is a cytosolic adaptor that localizes to the Golgi and secretory vesicle membranes, positioning it perfectly to mediate the formation and trafficking of secretory vesicles.

Role in Secretory Vesicle Formation and Trafficking

One of the primary functions of ICA1 is the regulation of secretory vesicle biogenesis in endocrine cells. This role has been elucidated through both cell-based experiments and animal models. ICA1 acts as a critical scaffolding protein in the early secretory pathway, ensuring that hormone and neurotransmitter cargo are properly packaged into dense-core secretory granules. A landmark study in 2008 by Buffa et al. showed that ICA1 directly interacts with the small GTPase Rab2 and regulates trafficking between the endoplasmic reticulum (ER) and Golgi (www.bioch.ox.ac.uk) (www.bioch.ox.ac.uk). Rab2 is known to control the transport of COPI-coated vesicles between the ER and Golgi. ICA1 was identified as a Rab2 effector that is recruited to Golgi membranes when Rab2 is in its active GTP-bound state (www.bioch.ox.ac.uk). Mechanistically, Rab2 binding targets ICA1 to sites of vesicle budding, where ICA1’s BAR domain can bind and deform membranes. Perturbing the levels of either Rab2 or ICA1 has significant consequences: Buffa and colleagues reported that overexpression of ICA1 (or Rab2) in insulinoma cells slowed anterograde trafficking of secretory granule proteins and reduced insulin secretion (www.bioch.ox.ac.uk). This dominant-negative effect suggests that precise amounts of ICA1 are needed for normal vesicle budding – too much ICA1 or Rab2 may “stall” or improperly curve the budding vesicles, highlighting ICA1’s role as a controller of vesicle formation kinetics. Consistently, depletion or loss of ICA1 also disrupts vesicle trafficking. In mice genetically engineered to lack ICA1, pancreatic β-cells exhibit defects in insulin storage and release (discussed further below) (journals.plos.org). Together, these findings position ICA1 as a key regulatory factor in the early secretory pathway, bridging the action of a GTPase (Rab2) with the physical process of vesicle budding at the ER–Golgi and Golgi–granule interface.

Beyond the ER–Golgi step, ICA1 is especially important at the level of immature secretory granule formation from the TGN. ICA1 commonly works in concert with another BAR domain protein called PICK1 (Protein Interacting with C Kinase 1). PICK1 and ICA1 form heterodimers that associate with secretory granules at specific stages of their maturation (journals.plos.org). Both proteins are banana-shaped BAR adapters that can sense membrane curvature. A 2013 study by Cao et al. (published in PLOS Biology) demonstrated that PICK1–ICA1 heteromeric complexes bind to immature insulin granules budding from the TGN, whereas mature granules retain PICK1 but lose ICA1 (journals.plos.org) (journals.plos.org). This suggests that ICA1’s role is most critical during the “birth” of new secretory granules – once the granule matures, ICA1 dissociates, and other factors (with PICK1 remaining) take over. Notably, treating cells with brefeldin A (to block new vesicle formation) led to an accumulation of both PICK1 and ICA1 at the TGN membrane (journals.plos.org), reinforcing that both proteins normally cycle on budding granules and that ICA1 in particular is recruited during the vesicle formation stage. The functional importance of ICA1 in this process was proven by genetic loss-of-function: mice lacking ICA1 exhibit impaired insulin granule maturation and secretion (journals.plos.org). ICA1 knockout mice have elevated blood glucose levels and increased proinsulin-to-insulin ratios in their pancreatic islets (journals.plos.org). In other words, without ICA1, insulin is not effectively packaged and processed in granules – proinsulin (the precursor) accumulates and less mature insulin is available for release. Similarly, mice lacking PICK1 display almost identical phenotypes, including glucose intolerance and defective insulin processing (journals.plos.org). Importantly, PICK1-deficient mice also show a complete loss of ICA1 protein in their islet β-cells (pubmed.ncbi.nlm.nih.gov). This indicates that ICA1’s stability or localization in cells depends on PICK1, and it suggests the two proteins function as a unit. The reverse may also be true: when ICA1 is absent, PICK1’s function in vesicle biogenesis is compromised. Indeed, these two BAR domain proteins have been dubbed “a pair of crescent-shaped proteins that shape vesicles at the Golgi” in commentary on the 2013 findings (pubmed.ncbi.nlm.nih.gov). In summary, ICA1’s primary function is to facilitate the budding of dense-core secretory granules, working together with PICK1 to mold membranes at the TGN so that hormones (like insulin, as well as other peptide hormones) are properly packaged for secretion (journals.plos.org). Without ICA1, secretory vesicles are abnormally formed, leading to hormone retention as precursor forms and insufficient release into the bloodstream (journals.plos.org).

Beyond insulin, ICA1’s role in vesicle formation extends to other endocrine systems. The PICK1–ICA1 complex has been implicated in the biogenesis of growth hormone (GH) secretory vesicles in the pituitary gland as well. Holst et al. (2013) found that in both Drosophila and mice, these two proteins cooperate to bud off GH-containing granules, and loss of PICK1 leads to GH insufficiency and stunted growth (pmc.ncbi.nlm.nih.gov). This generalizes the concept that ICA1 is not exclusive to insulin trafficking; it appears to be a universal regulator of dense-core vesicles in multiple cell types. In line with this, the earlier-mentioned C. elegans homolog RIC-19 works with the worm Rab2 (UNC-108) to ensure proper maturation of dense-core vesicles in neurons (pubmed.ncbi.nlm.nih.gov). Worms lacking RIC-19 or Rab2 show loss of specific neuropeptide cargo from vesicles, underscoring a conserved function in cargo packaging (pubmed.ncbi.nlm.nih.gov). Taken together, a broad picture emerges: ICA1 is a scaffold that links membrane curvature to vesicle content sorting, ensuring that secretory vesicles form correctly and carry the proper cargo. It acts at the crossroads of small GTPase signaling (Rab2 and possibly others) and the biophysical sculpting of the vesicle membrane (via BAR domain interactions). This positions ICA1 as an essential component of the secretory pathway, particularly for the biogenesis and maturation of dense-core secretory granules that store hormones and neuropeptides.

Interaction with PICK1 and Neuronal Functions

A major interacting partner of ICA1 is PICK1, and their partnership has functional consequences not only in endocrine cells but also in the nervous system. PICK1 is a multi-functional scaffold protein that contains a PDZ domain (which binds specific membrane protein tails) and a BAR domain. The ICA1–PICK1 heterodimer leverages both proteins’ BAR domains to form a composite curvature-sensing module, while PICK1’s PDZ domain connects to cargo proteins. In neurons, one of PICK1’s well-known roles is regulating the trafficking of AMPA-type glutamate receptors (AMPARs) at synapses, via its PDZ interaction with AMPAR subunits (GluA2/3) (pmc.ncbi.nlm.nih.gov). Emerging research indicates that ICA1 participates in this process, linking secretory vesicle trafficking to synaptic receptor modulation. Proteomic studies found ICA1 in complexes with AMPA receptor subunits in the brain, suggesting ICA1 is present at excitatory synapses through its binding to PICK1 (pmc.ncbi.nlm.nih.gov). Shu-Ling Chiu and colleagues (2023) recently demonstrated that ICA1 is required for certain forms of synaptic plasticity (pmc.ncbi.nlm.nih.gov). Specifically, mice lacking ICA1 have normal basal synaptic transmission but show a selective impairment in long-term potentiation (LTP) in the hippocampus, a brain region critical for learning and memory (pmc.ncbi.nlm.nih.gov). LTP is a strengthening of synapses often associated with an activity-dependent increase in the number of AMPA receptors at the synaptic membrane. In ICA1 knockout mice, while baseline levels of AMPA receptors and basic synaptic currents were unchanged, activity-dependent insertion of AMPARs during LTP was defective (pmc.ncbi.nlm.nih.gov). This led to deficiencies in hippocampus-dependent learning tasks, linking ICA1-mediated trafficking to cognitive function (pmc.ncbi.nlm.nih.gov). Notably, the loss of ICA1 did not affect long-term depression (LTD), the process of AMPAR removal from synapses (pmc.ncbi.nlm.nih.gov). This divergence is telling: PICK1 is heavily implicated in LTD (facilitating receptor endocytosis), whereas ICA1 appears to be more important for the opposite process – the delivery of receptors (or other proteins) during potentiation (pmc.ncbi.nlm.nih.gov). In essence, ICA1 supports the forward trafficking (secretory insertion) of neurotransmitter receptors, complementing PICK1’s role in retrieval and endocytosis.

Mechanistically, how does ICA1 influence synaptic AMPAR delivery? The 2023 study found that ICA1 regulates the localization and stability of PICK1 in neurons (pmc.ncbi.nlm.nih.gov). In ICA1 knockout neurons, PICK1’s distribution was altered and its protein levels in the hippocampus were reduced (pmc.ncbi.nlm.nih.gov). This mirrors the finding in β-cells that PICK1 requires ICA1 for stability (recall that PICK1 KO led to loss of ICA1, and here ICA1 KO impacts PICK1 levels – illustrating a mutual dependence) (pubmed.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). By keeping PICK1 appropriately localized, ICA1 likely ensures that AMPA receptors are cycled through the secretory pathway correctly. One possibility is that ICA1–PICK1 complexes in neurons help shuttle newly synthesized AMPA receptors from the Golgi out to the synaptic membrane (the so-called de novo secretory pathway for AMPARs) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This pathway is less studied than receptor recycling, but evidence suggests it plays a role in delivering fresh receptors during sustained synaptic strengthening (pmc.ncbi.nlm.nih.gov). The absence of ICA1 could specifically impair this forward delivery route, thus limiting the receptors available for LTP, even though the recycling/endocytosis route (involving PICK1 alone) remains intact for LTD. Earlier work by Cao et al. (2007) had already hinted at ICA1’s involvement in neuronal receptor trafficking: they reported that PICK1–ICA1 complexes regulate the synaptic targeting and surface expression of AMPA receptors (journals.plos.org). The new 2023 findings solidify that concept and tie it to functional plasticity changes and memory behavior.

In summary, ICA1 in the brain functions as a secretory trafficking protein that partners with PICK1 to influence neurotransmitter receptor placement at synapses. It is not a classical signaling molecule on its own (it does not catalyze signaling reactions or directly bind neurotransmitters), but by controlling the movement of receptor-containing vesicles, ICA1 has a significant impact on synaptic signaling. This role is conceptually similar to its function in endocrine cells: in both cases, ICA1 helps prepare and deliver vesicles loaded with important cargo (insulin in β-cells, AMPA receptors in neurons) to their proper destination (the cell surface) at the right time. Thus, ICA1 serves a broader structural and adaptor role in cells – orchestrating vesicle budding and cargo delivery in both secretory endocrine pathways and neuronal synaptic pathways.

Signaling Pathways and Molecular Interactions

Although ICA1 is primarily a structural adaptor in vesicle biogenesis, its actions intersect with various signaling pathways through the proteins it interacts with. One key pathway is linked to the small GTPase Rab2, as mentioned above. By acting as a Rab2 effector, ICA1 becomes part of the ER-to-Golgi trafficking machinery that is essential for maintaining the flow of secretory proteins (www.bioch.ox.ac.uk). This places ICA1 downstream of Rab2 activation; when Rab2 is active, it recruits ICA1, which in turn helps deform membranes and perhaps select cargo. There is also evidence that ICA1 may interface with Arf GTPases or coat proteins indirectly, due to its arfaptin-homology (arfaptins typically bind Arf family GTPases). Indeed, ICA1 was described as “arfaptin-related” and associated with the Golgi, hinting that it might share functional similarities with arfaptin-2 (also called PICK1 in some older literature, though PICK1 is a distinct gene) (pmc.ncbi.nlm.nih.gov). This suggests ICA1 could be part of a network of GTPase-regulated adaptors that coordinate membrane trafficking events (Rab2 at the ERGIC/Golgi, possibly Arfs at the TGN).

Another interaction of signaling relevance is with protein kinase C (PKC) pathways via PICK1. PICK1 was originally identified as a PKC-binding protein (hence “protein interacting with C-kinase”), and it can tether PKCα in neurons. Recent studies have uncovered a link between ICA1, PICK1, and PKCα signaling that has implications for Alzheimer’s disease (AD) pathology. In 2024, Ji et al. reported that ICA1 expression is decreased in the brains of Alzheimer’s patients and model mice, and that modulating ICA1 levels affects the processing of the Amyloid Precursor Protein (APP) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In cellular models, overexpression of ICA1 shifted APP processing away from the amyloidogenic pathway toward the non-amyloidogenic pathway (pmc.ncbi.nlm.nih.gov). Specifically, ICA1 increased the levels of the alpha-secretases ADAM10 and ADAM17 (which cut APP in a way that prevents toxic amyloid-β formation) (pmc.ncbi.nlm.nih.gov). It did not change APP gene expression or protein stability, but instead seemed to influence cell signaling such that more ADAM10/17 activity was directed at APP (pmc.ncbi.nlm.nih.gov). Transcriptomic analysis in that study suggested ICA1 regulates G-protein coupled receptor signaling networks, and notably ICA1 overexpression enhanced the abundance and phosphorylation of PKCα (pmc.ncbi.nlm.nih.gov). PKCα activation is known to stimulate ADAM17 and non-amyloidogenic APP cleavage, so this finding connects the dots: ICA1 might promote PKCα signaling via its interaction with PICK1, since PICK1 can bind and cluster PKCα. By stabilizing PICK1 (as seen in neurons) or positioning a PKC–PICK1 complex at membranes, ICA1 could facilitate PKCα activation of ADAM10/17, thus biasing APP processing towards a pathway less likely to produce amyloidogenic peptides. The authors concluded that ICA1 “shifts APP processing to non-amyloid pathways” by regulating the PICK1–PKCα axis, and they proposed ICA1 as a potential therapeutic target for AD (pmc.ncbi.nlm.nih.gov). This is a striking example of how a vesicle trafficking protein can influence a signaling cascade with disease relevance. It suggests that ICA1’s role in trafficking extends into modulation of signaling enzymes (like PKCα) by controlling their localization or assembly with substrates. While this connection is still being unraveled, it highlights that ICA1 is embedded in a web of cellular pathways: it interacts with small GTPases (Rab2), scaffold proteins (PICK1), and potentially kinases (PKCα), thereby linking membrane trafficking to signal transduction outcomes.

It’s worth noting that ICA1 itself is not known to have direct catalytic activity or to function as a classical signaling receptor or ligand. Instead, its contribution to pathways is through adaptor functions – it brings together molecules (for example, helping PICK1 to cluster with PKCα, or enabling Rab2 to effect membrane changes). Through these interactions, ICA1 can influence insulin signaling indirectly (by controlling insulin secretion), synaptic signaling (by controlling neurotransmitter receptor availability), and even cellular stress or growth signals (given that dense-core vesicles also carry neuropeptides and hormones like growth hormone). In the pituitary and pancreatic context, for instance, proper vesicle maturation under ICA1’s guidance ensures that hormonal signals (insulin, growth hormone) are released appropriately in response to physiological cues (pmc.ncbi.nlm.nih.gov). If ICA1 is dysfunctional, those signaling pathways (glucose homeostasis, growth regulation) suffer downstream effects (e.g., diabetes-like phenotypes or growth defects) (journals.plos.org) (pmc.ncbi.nlm.nih.gov). Thus, while ICA1 is not a signaling enzyme, it is intimately connected to multiple signaling pathways through the vesicular cargo it helps manage and the protein complexes it forms.

Clinical and Biomedical Significance

Autoantigen in Type 1 Diabetes: ICA1 was originally discovered in the context of autoimmune diabetes; autoantibodies against a 69 kDa islet cell protein (ICA69) were detected in patients with type 1 diabetes mellitus (T1D) and in some of their relatives years before disease onset (pmc.ncbi.nlm.nih.gov). Subsequent research confirmed that both B-cell and T-cell responses against ICA1 can occur in T1D (pmc.ncbi.nlm.nih.gov). However, compared to major islet autoantigens like insulin, GAD65, IA-2, and ZnT8, ICA69 autoantibodies are less prevalent and are not part of the standard clinical autoantibody panel for diabetes prediction (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). They do appear in a subset of patients and even in other autoimmune disorders such as Sjögren’s syndrome and rheumatoid arthritis (in those diseases, the presence of ICA69 antibodies is thought to reflect immune cross-reactivity due to some shared antigenic epitopes or co-occurrence of autoimmune conditions) (www.wikidoc.org) (pmc.ncbi.nlm.nih.gov). The biological reason ICA1 breaks immune tolerance in some individuals is still being studied. Intriguingly, one hypothesis is that ICA1’s involvement in secretory granule biology links it to β-cell stress. During diabetogenesis, misfolded proteins or abnormal secretory granules in β-cells might lead to the release or abnormal presentation of ICA1 peptides, triggering autoimmunity (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Another line of evidence comes from the role of the AIRE gene in thymic education: mouse studies have shown that lower expression of Ica1 in the thymus (due to certain polymorphisms) can result in incomplete deletion of ICA69-reactive T cells, predisposing to multi-organ autoimmunity (pmc.ncbi.nlm.nih.gov). Indeed, mice lacking ICA1 (Ica1 knockout) are resistant to autoimmune diabetes in the NOD mouse model (journals.plos.org) – presumably because the immune system has no target to attack – yet these same mice suffer the consequences of impaired insulin secretion as described earlier. Thus, ICA1 sits at an interesting intersection of endocrinology and immunology: it is essential for normal β-cell function, but it can also become a victim of the immune system in T1D. This duality has prompted interest in ICA1 as a factor in diabetes pathogenesis, though targeting it for therapy is complex (completely removing ICA1 might blunt autoimmunity but at the cost of secretory function). Some researchers have suggested that measuring ICA69-specific T cells or antibodies could add information in understanding atypical or multi-autoimmune cases (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov), especially since ICA1 is also expressed in brain and other organs, possibly contributing to other autoimmune manifestations when central tolerance is compromised (pmc.ncbi.nlm.nih.gov).

Neurodegeneration and Other Diseases: Beyond autoimmunity, recent studies suggest ICA1 could be relevant in neurodegenerative and cognitive disorders. The 2024 study linking ICA1 to Alzheimer’s disease (AD) found that brains of AD patients have significantly lower ICA1 levels compared to age-matched controls (pmc.ncbi.nlm.nih.gov). While the causal direction is not established, the data showed that boosting ICA1 had protective biochemical effects: it upregulated non-amyloidogenic APP cleavage (increasing ADAM10/17 and soluble APPα production) (pmc.ncbi.nlm.nih.gov). Moreover, ICA1 overexpression in cellular models activated PKCα – a kinase known to be neuroprotective when it enhances α-secretase activity (pmc.ncbi.nlm.nih.gov). These findings hint that ICA1 might normally support neuronal health by promoting beneficial signaling pathways (like PKC/α-secretase), and its decline in AD could remove this support, tilting APP processing toward the harmful amyloid-producing route. If further research confirms this mechanism, ICA1 or its downstream effects could become therapeutic targets. For instance, small molecules or biologics that stabilize the ICA1–PICK1 interaction or enhance ICA1 expression might foster a shift toward non-amyloidogenic APP processing, offering a novel strategy to reduce Aβ accumulation in AD (pmc.ncbi.nlm.nih.gov). It is early to translate this into clinics, but it exemplifies how fundamental cell biology of a vesicle protein can unexpectedly point to disease-modifying approaches.

In neurological research, ICA1’s role in synaptic plasticity (as described earlier) also suggests relevance for cognitive disorders. The ICA1 knockout mice showed deficits in spatial learning (pmc.ncbi.nlm.nih.gov), which raises the question of whether variations in the ICA1 gene or protein levels in humans could contribute to learning disabilities or memory impairment. So far, no specific human mutations in ICA1 have been definitively linked to neurological syndromes. However, given that ICA1 has a close paralog (ICA1L) and is part of a larger network, subtle perturbations might have been overlooked. Ongoing research in molecular neuroscience is likely to further explore ICA1’s role in brain functions and whether it could be a factor in disorders of synaptic dysfunction.

Finally, it’s worth noting that ICA1 has been examined in the context of cancer (because many proteins related to secretion can influence tumor cell secretory phenotypes) and other metabolic conditions. For example, some data exist on insulinomas (insulin-secreting pancreatic tumors) where ICA1 is highly expressed, as expected for β-cell origin, and occasionally its autoantigen status has been exploited for diagnostic imaging or immune-based therapies in experimental settings (www.genecards.org). However, such applications are still exploratory.

Conclusion

ICA1 (Q05084) encodes a multi-functional adaptor protein that plays a crucial role in the formation and function of secretory vesicles. In essence, ICA1 acts as a molecular scaffold at the Golgi and on immature secretory granules, using its BAR domain to mold membranes and partnering with proteins like PICK1 and Rab2 to ensure that hormones and receptors are properly packaged for secretion. The current understanding, supported by cross-species studies and gene knockout models, is that ICA1 is a conserved regulator of neuroendocrine secretion (pmc.ncbi.nlm.nih.gov), indispensable for processes ranging from insulin granule maturation in pancreatic β-cells to neurotransmitter receptor trafficking in neurons. Recent research (2023–2024) has expanded the significance of ICA1, connecting it to higher-order physiological outcomes: synaptic plasticity and memory formation are impaired without ICA1 (pmc.ncbi.nlm.nih.gov), and even pathways relevant to Alzheimer’s disease may be modulated by ICA1 via PICK1–PKCα interactions (pmc.ncbi.nlm.nih.gov). These developments underscore the gene’s broad impact. ICA1’s primary function is structural – it does not catalyze reactions or transport ions, but it provides a physical platform that shapes vesicles and positions key molecules where they are needed in the cell. Its subcellular localization to the cytosolic face of Golgi and secretory vesicle membranes is absolutely integral to this role, as it operates at the nexus of vesicle budding and cargo sorting (www.wikidoc.org) (journals.plos.org). In terms of pathways, ICA1 is entwined with the secretory pathway (ER-to-Golgi transport, granule biogenesis) and with intracellular signaling cascades indirectly (through effects on PKC and possibly other kinases).

From a biomedical perspective, ICA1 illustrates how a protein can be simultaneously a basic cellular workhorse and a factor in disease contexts. As an autoantigen, it provided early clues into T1D pathogenesis, and as a trafficking protein, it continues to reveal new biology in metabolism and brain function. Ongoing studies are likely to further clarify how ICA1’s interactions (with Rab GTPases, BAR domain partners, and PDZ domain proteins) are regulated and how they might be leveraged to treat diseases of secretion or protein misprocessing. In summary, ICA1/ICA69 is now recognized as a pivotal component of the cellular machinery for secretory vesicle formation and a guardian of proper cargo delivery, with impacts that resonate from endocrine hormone release to synaptic receptor distribution. This comprehensive understanding is built on a foundation of precise experimental evidence, ranging from biochemical binding assays and imaging of granules (www.bioch.ox.ac.uk) (journals.plos.org) to whole-animal physiology tests (glucose tolerance, behavioral assays) in ICA1 mutant mice (journals.plos.org) (pmc.ncbi.nlm.nih.gov), all converging on the idea that ICA1 is essential for the fidelity of the secretory system in human cells.

Citations

1. AnnotationURLCitation(end_index=300, start_index=210, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=ICA69')
2. AnnotationURLCitation(end_index=511, start_index=415, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=,M213222200')
3. AnnotationURLCitation(end_index=782, start_index=648, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=Islet%20cell%20autoantigen%20of%2069,ICA512%20and')
4. AnnotationURLCitation(end_index=1062, start_index=957, title='ICA1 - wikidoc', type='url_citation', url='https://www.wikidoc.org/index.php/ICA1#:~:text=This%20gene%20encodes%20a%20protein,1')
5. AnnotationURLCitation(end_index=1276, start_index=1149, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L528%20Ica1%2C%20is,ICA69%20is')
6. AnnotationURLCitation(end_index=2115, start_index=2025, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=ICA69')
7. AnnotationURLCitation(end_index=2522, start_index=2330, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=the%20biogenesis%20and%20maturation%20of,Mice%20lacking%20functional%20PICK1%20or')
8. AnnotationURLCitation(end_index=2716, start_index=2620, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=,M213222200')
9. AnnotationURLCitation(end_index=3126, start_index=3021, title='ICA1 - wikidoc', type='url_citation', url='https://www.wikidoc.org/index.php/ICA1#:~:text=This%20gene%20encodes%20a%20protein,1')
10. AnnotationURLCitation(end_index=3314, start_index=3218, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=,M213222200')
11. AnnotationURLCitation(end_index=3640, start_index=3455, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water')
12. AnnotationURLCitation(end_index=3731, start_index=3641, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=ICA69')
13. AnnotationURLCitation(end_index=4316, start_index=4182, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=Islet%20cell%20autoantigen%20of%2069,ICA512%20and')
14. AnnotationURLCitation(end_index=4848, start_index=4721, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L528%20Ica1%2C%20is,ICA69%20is')
15. AnnotationURLCitation(end_index=5163, start_index=5023, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=Islet,are%20conserved%20regulators%20of%20neuroendocrine')
16. AnnotationURLCitation(end_index=5749, start_index=5564, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water')
17. AnnotationURLCitation(end_index=6057, start_index=5866, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=different%20stages%20of%20their%20maturation,to%20increased%20food%20and%20water')
18. AnnotationURLCitation(end_index=7087, start_index=6953, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=Islet%20cell%20autoantigen%20of%2069,ICA512%20and')
19. AnnotationURLCitation(end_index=7246, start_index=7088, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in')
20. AnnotationURLCitation(end_index=7618, start_index=7460, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in')
21. AnnotationURLCitation(end_index=8163, start_index=8005, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in')
22. AnnotationURLCitation(end_index=8834, start_index=8633, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
23. AnnotationURLCitation(end_index=9613, start_index=9428, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water')
24. AnnotationURLCitation(end_index=10099, start_index=9914, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water')
25. AnnotationURLCitation(end_index=10301, start_index=10100, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
26. AnnotationURLCitation(end_index=10829, start_index=10638, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=different%20stages%20of%20their%20maturation,to%20increased%20food%20and%20water')
27. AnnotationURLCitation(end_index=11349, start_index=11148, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
28. AnnotationURLCitation(end_index=11676, start_index=11475, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
29. AnnotationURLCitation(end_index=12192, start_index=11991, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
30. AnnotationURLCitation(end_index=12454, start_index=12297, title='PICK1 and ICA69 control insulin granule trafficking and their deficiencies lead to impaired glucose tolerance - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23630453/#:~:text=in%20mice%20caused%20the%20complete,and%20maturation%20of%20insulin%20granules')
31. AnnotationURLCitation(end_index=12955, start_index=12855, title='PICK1 and ICA69 control insulin granule trafficking and their deficiencies lead to impaired glucose tolerance - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23630453/#:~:text=Comment%20in%20,PICK1')
32. AnnotationURLCitation(end_index=13412, start_index=13220, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=the%20biogenesis%20and%20maturation%20of,Mice%20lacking%20functional%20PICK1%20or')
33. AnnotationURLCitation(end_index=13756, start_index=13564, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=the%20biogenesis%20and%20maturation%20of,Mice%20lacking%20functional%20PICK1%20or')
34. AnnotationURLCitation(end_index=14348, start_index=14174, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=biogenesis%20of%20insulin%20secretory%20vesicles,major%20scaffold%20protein%20for%20AMPAR')
35. AnnotationURLCitation(end_index=14824, start_index=14682, title='TBC-8, a putative RAB-2 GAP, regulates dense core vesicle maturation in Caenorhabditis elegans - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/22654674/#:~:text=Caenorhabditis%20elegans%20,specific%20cargo%20is%20lost%20from')
36. AnnotationURLCitation(end_index=15106, start_index=14964, title='TBC-8, a putative RAB-2 GAP, regulates dense core vesicle maturation in Caenorhabditis elegans - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/22654674/#:~:text=Caenorhabditis%20elegans%20,specific%20cargo%20is%20lost%20from')
37. AnnotationURLCitation(end_index=16531, start_index=16366, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=in%20the%20biogenesis%20of%20secretory,and%20morphological%20analysis%20of%20CA1')
38. AnnotationURLCitation(end_index=17000, start_index=16835, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=in%20the%20biogenesis%20of%20secretory,and%20morphological%20analysis%20of%20CA1')
39. AnnotationURLCitation(end_index=17300, start_index=17127, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
40. AnnotationURLCitation(end_index=17628, start_index=17510, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=levels,dependent%20learning%20and')
41. AnnotationURLCitation(end_index=18120, start_index=17947, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
42. AnnotationURLCitation(end_index=18421, start_index=18248, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
43. AnnotationURLCitation(end_index=18712, start_index=18539, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
44. AnnotationURLCitation(end_index=19122, start_index=18949, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
45. AnnotationURLCitation(end_index=19619, start_index=19452, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=the%20AMPAR%20protein%20complex%20through,ICA69%20does%20not%20regulate%20synaptic')
46. AnnotationURLCitation(end_index=19902, start_index=19735, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=the%20AMPAR%20protein%20complex%20through,ICA69%20does%20not%20regulate%20synaptic')
47. AnnotationURLCitation(end_index=20253, start_index=20096, title='PICK1 and ICA69 control insulin granule trafficking and their deficiencies lead to impaired glucose tolerance - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23630453/#:~:text=in%20mice%20caused%20the%20complete,and%20maturation%20of%20insulin%20granules')
48. AnnotationURLCitation(end_index=20421, start_index=20254, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=the%20AMPAR%20protein%20complex%20through,ICA69%20does%20not%20regulate%20synaptic')
49. AnnotationURLCitation(end_index=20883, start_index=20760, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=Long,to%20the%20cell%20surface%2C%20or')
50. AnnotationURLCitation(end_index=21060, start_index=20884, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=trafficking%20pathways%20regulate%20the%20surface,plasticity%20and%20animal%20behavior%20by')
51. AnnotationURLCitation(end_index=21405, start_index=21224, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=synapse%20trapping%20and%20subsequent%20endocytosis%2C,plasticity%20and%20animal%20behavior%20by')
52. AnnotationURLCitation(end_index=21975, start_index=21847, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=19,View%20Article')
53. AnnotationURLCitation(end_index=23570, start_index=23412, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in')
54. AnnotationURLCitation(end_index=24217, start_index=24121, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=,M213222200')
55. AnnotationURLCitation(end_index=25133, start_index=24985, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Islet%20cell%20autoantigen%201%20,and%20an%20AD%20mouse%20model')
56. AnnotationURLCitation(end_index=25293, start_index=25134, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Our%20results%20demonstrated%20that%20ICA1,for%20the%20treatment%20of%20AD')
57. AnnotationURLCitation(end_index=25533, start_index=25438, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Conclusion')
58. AnnotationURLCitation(end_index=25861, start_index=25682, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=The%20ICA1%20increased%20the%20expression,PKC%CE%B1%20protein%20levels%20and%20phosphorylation')
59. AnnotationURLCitation(end_index=26203, start_index=26024, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=The%20ICA1%20increased%20the%20expression,PKC%CE%B1%20protein%20levels%20and%20phosphorylation')
60. AnnotationURLCitation(end_index=26545, start_index=26402, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=17%20,PKC%CE%B1%20protein%20levels%20and%20phosphorylation')
61. AnnotationURLCitation(end_index=27350, start_index=27191, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Our%20results%20demonstrated%20that%20ICA1,for%20the%20treatment%20of%20AD')
62. AnnotationURLCitation(end_index=29001, start_index=28827, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=biogenesis%20of%20insulin%20secretory%20vesicles,major%20scaffold%20protein%20for%20AMPAR')
63. AnnotationURLCitation(end_index=29373, start_index=29172, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
64. AnnotationURLCitation(end_index=29548, start_index=29374, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=biogenesis%20of%20insulin%20secretory%20vesicles,major%20scaffold%20protein%20for%20AMPAR')
65. AnnotationURLCitation(end_index=30200, start_index=30063, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L535%20ICA69%20can,Second%2C%20T%20cells')
66. AnnotationURLCitation(end_index=30437, start_index=30300, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L535%20ICA69%20can,Second%2C%20T%20cells')
67. AnnotationURLCitation(end_index=30770, start_index=30647, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=Anti,T1D%20and%20SPIDDM%20cases%20were')
68. AnnotationURLCitation(end_index=30873, start_index=30771, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=diabetes%20,islet')
69. AnnotationURLCitation(end_index=31290, start_index=31185, title='ICA1 - wikidoc', type='url_citation', url='https://www.wikidoc.org/index.php/ICA1#:~:text=This%20gene%20encodes%20a%20protein,1')
70. AnnotationURLCitation(end_index=31432, start_index=31291, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=Seminal%20studies%20by%20Atkinson%20et,cell%20injury%20in')
71. AnnotationURLCitation(end_index=31968, start_index=31822, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=in%20the%20neuroendocrine%20system,In%20this%20context%2C%20we')
72. AnnotationURLCitation(end_index=32137, start_index=31969, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=autoantigens%20play%20diverse%20roles%20in,GAD65%2C%20ZnT8%2C%20IA2%2C%20and%20ICA69')
73. AnnotationURLCitation(end_index=32595, start_index=32424, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L539%20autoreactive%20to,expression%20in%20medullary%20thymic%20epithelial')
74. AnnotationURLCitation(end_index=32878, start_index=32703, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=match%20at%20L134%20while%20ICA69,accelerated%20diabetes%20%5B25')
75. AnnotationURLCitation(end_index=33735, start_index=33598, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L535%20ICA69%20can,Second%2C%20T%20cells')
76. AnnotationURLCitation(end_index=33906, start_index=33736, title='Compromised central tolerance of ICA69 induces multiple organ autoimmunity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4704797/#:~:text=For%20reasons%20not%20fully%20understood%2C,%CE%94ICA69%20line.%20Suboptimal%20central')
77. AnnotationURLCitation(end_index=34242, start_index=34072, title='Compromised central tolerance of ICA69 induces multiple organ autoimmunity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4704797/#:~:text=For%20reasons%20not%20fully%20understood%2C,%CE%94ICA69%20line.%20Suboptimal%20central')
78. AnnotationURLCitation(end_index=34711, start_index=34563, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Islet%20cell%20autoantigen%201%20,and%20an%20AD%20mouse%20model')
79. AnnotationURLCitation(end_index=35107, start_index=34928, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=The%20ICA1%20increased%20the%20expression,PKC%CE%B1%20protein%20levels%20and%20phosphorylation')
80. AnnotationURLCitation(end_index=35393, start_index=35250, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=17%20,PKC%CE%B1%20protein%20levels%20and%20phosphorylation')
81. AnnotationURLCitation(end_index=36152, start_index=35993, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Our%20results%20demonstrated%20that%20ICA1,for%20the%20treatment%20of%20AD')
82. AnnotationURLCitation(end_index=36689, start_index=36516, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
83. AnnotationURLCitation(end_index=37874, start_index=37748, title='ICA1 Gene - GeneCards | ICA69 Protein | ICA69 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=ICA1#:~:text=GeneCards%20Summary%20for%20ICA1%20Gene')
84. AnnotationURLCitation(end_index=38643, start_index=38503, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=Islet,are%20conserved%20regulators%20of%20neuroendocrine')
85. AnnotationURLCitation(end_index=39149, start_index=38976, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
86. AnnotationURLCitation(end_index=39413, start_index=39254, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Our%20results%20demonstrated%20that%20ICA1,for%20the%20treatment%20of%20AD')
87. AnnotationURLCitation(end_index=39987, start_index=39882, title='ICA1 - wikidoc', type='url_citation', url='https://www.wikidoc.org/index.php/ICA1#:~:text=This%20gene%20encodes%20a%20protein,1')
88. AnnotationURLCitation(end_index=40173, start_index=39988, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water')
89. AnnotationURLCitation(end_index=41519, start_index=41361, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in')
90. AnnotationURLCitation(end_index=41705, start_index=41520, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water')
91. AnnotationURLCitation(end_index=41999, start_index=41798, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
92. AnnotationURLCitation(end_index=42173, start_index=42000, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')

ICA1 Gene Annotation Review Notes

Review Date: 2025-11-16

Summary

Systematic review of all 22 existing GO annotations for human ICA1 (Islet Cell Autoantigen 1).

Review Statistics

• Total annotations reviewed: 22
• ACCEPT: 20 annotations
• MODIFY: 2 annotations (both "protein binding" terms)
• REMOVE: 0 annotations
• NEW: 0 annotations suggested

Gene Function Overview

ICA1 (Q05084) is a ~69 kDa BAR domain-containing protein that serves as a critical regulator of dense-core secretory vesicle biogenesis in neuroendocrine cells. Key functional features:

1. Primary Molecular Function: Membrane curvature sensor activity (GO:0140090)
2. Mediated by BAR domain and N-terminal amphipathic helix

3. Demonstrated by direct experimental evidence PMID:29768204

4. Core Biological Process: Regulation of secretion (GO:0051046)

5. Essential for insulin granule maturation in pancreatic β-cells
6. Regulates AMPA receptor trafficking in neurons

7. Ica1 knockout mice show impaired insulin secretion and glucose homeostasis

8. Key Protein Interactions:

9. Forms stable heterodimers with PICK1 (BAR domain protein)
10. Functions as Rab2 effector linking GTPase signaling to vesicle formation

11. PICK1-ICA1 complexes orchestrate granule formation at TGN

12. Subcellular Localization:

13. Predominantly cytosolic with dynamic membrane association
14. Transiently associates with Golgi/TGN membranes
15. Binds immature secretory granules (dissociates upon maturation)
16. Present on synaptic vesicle membranes in neurons

Key Annotation Decisions

ACCEPT Decisions (20 annotations)

All phylogenetically-inferred (IBA) annotations were accepted as they are well-supported by experimental evidence:
- GO:0030667 (secretory granule membrane) - IBA - Core vesicle localization
- GO:0051046 (regulation of secretion) - IBA - Central biological function
- GO:0097753 (membrane bending) - IBA - BAR domain mechanistic function
- GO:0140090 (membrane curvature sensor activity) - IBA - Primary molecular function

Direct experimental annotations (IDA) were all accepted:
- GO:0000139 (Golgi membrane) from PMID:12682071 - Confocal microscopy & fractionation
- GO:0030667 (secretory granule membrane) from PMID:12682071 - Immunoelectron microscopy
- GO:0140090 (membrane curvature sensor activity) from PMID:29768204 - Super-resolution microscopy
- GO:0005829 (cytosol) from GO_REF:0000052 - HPA immunofluorescence

Electronic annotations (IEA) were accepted as accurate automated mappings from UniProt:
- Cellular component terms correctly mapped from UniProt subcellular location vocabulary
- Appropriately broad terms like GO:0012505 (endomembrane system)
- GO:0006836 (neurotransmitter transport) accurate despite being indirect

Sequence similarity annotations (ISS) from mouse ortholog were accepted:
- GO:0005829 (cytosol) - Conservative inference from P97411
- GO:0030672 (synaptic vesicle membrane) - Supported by UniProt data

Historical TAS annotation accepted:
- GO:0005737 (cytoplasm) from PMID:8326004 - Original gene discovery paper

MODIFY Decisions (2 annotations)

Both instances of "protein binding" (GO:0005515) were marked for modification:

1. PMID:25416956 (IPI) - Proteome-scale interactome study
2. Rationale: Generic "protein binding" lacks functional specificity
3. ICA1 is a scaffolding protein and Rab2 effector

4. Proposed replacements:

   • GO:0030674 (protein-macromolecule adaptor activity)
   • GO:0043495 (protein-membrane adaptor activity)

5. PMID:29892012 (IPI) - High-throughput interactome perturbation study

6. Same rationale as above
7. Study focused on interaction-disrupting mutations but doesn't provide functional insight
8. Same proposed replacements

Rationale for MODIFY rather than ACCEPT: While "protein binding" is technically correct, it provides no information about ICA1's actual function. For a scaffolding/adaptor protein, more specific molecular function terms that capture its role in bringing together membrane components and protein partners would be more informative. The curation guideline explicitly states to "avoid the term 'protein binding'" as it "doesn't tell us anything about the actual function."

REMOVE Decisions (0 annotations)

No annotations were marked for removal. All existing annotations accurately reflect some aspect of ICA1 biology, even if some could be more specific.

Supporting Literature

Key Primary Research Papers

1. PMID:12682071 (Spitzenberger et al. 2003)
2. First detailed subcellular localization study
3. Demonstrated Golgi and secretory granule association
4. Identified ICA1 as arfaptin-related protein

5. Evidence: confocal microscopy, subcellular fractionation, immunoelectron microscopy

6. PMID:29768204 (Herlo et al. 2018)

7. Mechanistic study of membrane curvature sensing
8. Identified amphipathic helix as critical structural element
9. Super-resolution microscopy on insulin granules

10. Showed size-dependent binding during granule maturation

11. PMID:8326004 (Pietropaolo et al. 1993)

12. Original ICA1 discovery and characterization
13. Identified as diabetes-associated autoantigen

14. Initial tissue distribution and cloning

15. PMID:25416956 (Rolland et al. 2014)

16. Large-scale human interactome mapping

17. Identified RAB2A, RAB2B, and other ICA1 interactions

18. PMID:29892012 (Chen et al. 2018)

19. Interactome perturbation framework
20. Studied impact of missense mutations on protein interactions

Additional Evidence Sources

• UniProt:Q05084 - Comprehensive protein annotation
• Deep research file - Literature synthesis on ICA1 function
• PICK1-ICA1 heterodimer formation
• Insulin granule maturation defects in Ica1-/- mice
• AMPA receptor trafficking in neurons
• C. elegans RIC-19 homolog function

Annotation Quality Assessment

Strengths

1. Good coverage of core molecular function (membrane curvature sensing)
2. Multiple experimental annotations (IDA) from high-quality studies
3. Conservative IBA annotations well-supported by literature
4. Appropriate subcellular localization annotations at multiple granularities

Areas for Improvement

1. The two "protein binding" annotations should be replaced with more specific molecular function terms
2. Could potentially add more specific process annotations related to:
3. Insulin secretion
4. AMPA receptor trafficking
5. Vesicle maturation
6. Missing annotation for Rab2 effector function (though implied by domain binding annotation)

Evolutionary Conservation

ICA1 function is highly conserved:
- Human ICA1 ↔ Mouse Ica1 (P97411) - high sequence similarity
- C. elegans RIC-19 - required for neuropeptide cargo packaging in dense-core vesicles
- Arfaptin-related protein family - conserved BAR domain function

This conservation supports the phylogenetic inference (IBA) annotations and validates ISS annotations from mouse.

Disease Relevance

1. Type 1 Diabetes: Discovered as diabetes autoantigen; autoantibodies in T1D patients
2. Alzheimer's Disease: Recent findings show ICA1 reduction in AD brains; overexpression shifts APP processing toward non-amyloidogenic pathway
3. Metabolic Dysfunction: Ica1-/- mice show impaired glucose tolerance

Recommendations

1. Immediate Action: Replace both "protein binding" annotations with more specific adaptor activity terms
2. Future Consideration:
3. Add process annotations for insulin secretion when evidence codes permit
4. Consider annotation extensions to capture PICK1 interaction
5. Document Rab2 effector function explicitly

Conclusion

The existing GO annotations for ICA1 are generally of high quality with strong experimental support. The major improvement needed is replacing generic "protein binding" terms with more functionally informative molecular function annotations that capture ICA1's role as a membrane-protein scaffolding adaptor in vesicle biogenesis.